Search
for
Sort by
Research 61–90 of 329
- Skin Disorders
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Avian-Inspired Analogies in Dermatology
- A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center
- JAK inhibitors in dermatology: The promise of a new drug class
- Dermatology Benefits of Licorice (Glycyrrhiza glabra L.): A Review of its Potential in Skin and Hair Disorders
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Keloids After Herpes Zoster: Report of Wolf’s Isotopic Phenomenon and Literature Review
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- COVID‐19 and cutaneous manifestations: A review of the published literature
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Chronic graft versus host disease and skin
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Herpes zoster ophthalmicus (HZO) secondary to platelet-rich plasma (PRP) therapy - A case report
- A concomitant diagnosis of COVID‐19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report
- Skin manifestations associated with COVID-19
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Vaccines, adjuvants and autoimmunity
- The Pathobiology of Skin Aging
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Autophagy: Guardian of Skin Barrier
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives